Clinical case of gonadotropinoma, which occurs for a long time under the guise of hyperprolactinemia
https://doi.org/10.14341/brh12710
Abstract
The prevalence of pituitary adenomas in the population among tumors of the central nervous system is about 17%. Pituitary adenomas are divided into non-functional (about 36–54%), characterized by the absence of secretory activity, and functional (about 46–64%), secreting hormones or their subunits. The most common are prolactinomas (32–51%), somatotropinomas (9– 11%), corticotropinomas (3–6%), the frequency of gonadotropins and thyrotropins is low and amounts to less than 1% of cases. This article presents a clinical observation of a patient with gonadotropinoma, which has been occurring for a long time under the guise of hyperprolactinemia.
About the Authors
T. V. Nikitina
Endocrinology Research Centre
Tatiana V. Nikitina, medical resident
11 Dm. Ulyanova street, 117036 Moscow
S. Yu. Vorotnikova
Endocrinology Research Centre
Russian Federation
Russian Federation
Svetlana Y. Vorotnikova, MD, PhD
11 Dm. Ulyanova street, 117036 Moscow
L. K. Dzeranova
Endocrinology Research Centre
Larisa K. Dzeranova, MD, PhD
11 Dm. Ulyanova street, 117036 Moscow
A. M. Lapshina
Endocrinology Research Centre
Anastasia M. Lapshina, MD, PhD
11 Dm. Ulyanova street, 117036 Moscow
V. N. Azizyan
Endocrinology Research Centre
Vilen N. Azizyan, MD, PhD
11 Dm. Ulyanova street, 117036 Moscow
A. G. Kuzmin
Endocrinology Research Centre
Anatoly G. Kuzmin, MD, PhD
11 Dm. Ulyanova street, 117036 Moscow
References
1. Gautam U. Mehta, Russell R. Lonser. Management of hormonesecreting pituitary adenomas. Neuro-Oncology. 2017;19(6):762-773. doi: https://doi.org/10.1093/neuonc/now130
2. Dedov II, Melnichenko GA, Rozhinskaya LYa, et al. Pituitary incidentalomas: the clinical picture, diagnostics, differential diagnostics, and methods of treatment. Problems of endocrinology. 2015;61(3):57–68. (In Russ). doi: https://doi.org/10.14341/probl201561357-68
3. Дедов И.И. Эндокринология: национальное руководство / Под ред. И.И. Дедова, Г.А. Мельниченко. — 2-е изд., перераб. и доп. — Москва: ГЭОТАР-Медиа, 2021. — 1112 с.: ил. — 1112 с. — ISBN 978-5-9704-6054-2
4. Du X, Zhang W, Wang X, et al. Follicle-Stimulating HormoneSecreting Pituitary Adenoma Inducing Spontaneous Ovarian Hyperstimulation Syndrome, Treatment Using In Vitro Fertilization and Embryo Transfer: A Case Report. Front. Endocrinol. 2021;12:621456. doi: https://doi.org/10.3389/fendo.2021.621456
5. David J. Cote, BS, Timothy R. Smith, et al. Functional Gonadotroph Adenomas: Case Series and Report of Literature. Neurosurgery. 2016;79(6):823-831. doi: https://doi.org/10.1227/NEU.0000000000001188
6. Dekkers OM, Pereira AM, Romijn JA. Treatment and followup of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab. 2008;93(10):3717-3726. doi: https://doi.org/10.1210/jc.2008-0643
7. Jaffe C.A. Clinically non-functioning pituitary adenoma. Pituitary. 2006;9:317-321. doi: https://doi.org/10.1007/s11102-006-0412-9.
8. Ogra S, Nichols AD, Stylli S, et al. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma. J Clin Neurosci. 2014;21(5):735-40. doi: https://doi.org/10.1016/j.jocn.2014.01.005
9. Ntali G, Wass JA. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary. 2018;21(2):111-118. doi: https://doi.org/10.1007/s11102-018-0869-3
10. Zhang F, Huang Y, Ding C, et al. The prevalence of hyperprolactinemia in non-functioning pituitary macroadenomas. Int J Clin Exp Med. 2015;8(10):18990-7
11. Lyu L, Yin S, Hu Y, et al. Hyperprolactinemia in clinical non-functional pituitary macroadenomas: A STROBEcompliant study. Medicine (Baltimore). 2020;99(41):e22673. doi: https://doi.org/10.1097/MD.0000000000022673
12. Yassin A, Doros G. Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss. Clin Obes. 2013; 3(3-4): 73–83. doi: https://doi.org/10.1111/cob.12022
13. Fraietta R, Zylberstejn DS, Esteves SC. Hypogonadotropic hypogonadism revisited. Clinics (Sao Paulo). 2013; 68 Suppl 1 (Suppl 1):81-88. doi: https://doi.org/10.6061/clinics/2013(sup01)09
14. Dedov II, Mokrysheva NG, Melnichenko GA, et al. Draft of Russian Clinical Practice Guidelines «Male hypogonadism». Obesity and metabolism. 2021;18(4):496-507. (In Russ.). doi: https://doi.org/10.14341/omet12817
15. Hong YG, Kim SH, Kim EH. Delayed Hyponatremia after Transsphenoidal Surgery for Pituitary Adenomas: A Single Institutional Experience. Brain Tumor Res Treat. 2021;9(1):16-20. doi: https://doi.org/10.14791/btrt.2021.9.e5
16. Lin K, Lu L, Pei Z, et al. Predictive factors for delayed hyponatremia after transsphenoidal surgery in patients with pituitary adenomas. Endocr Connect. 2022;11(1):e210497. doi: https://doi.org/10.1530/EC-21-0497
17. Olson BR, Gumowski J, Rubino D, Oldfield EH. Pathophysiology of hyponatremia after transsphenoidal pituitary surgery. J Neurosurg. 1997;87(4):499-507. doi: https://doi.org/10.3171/jns.1997.87.4.0499
18. Hussain NS, Piper M, Ludlam WG, et al. Delayed postoperative hyponatremia after transsphenoidal surgery: prevalence and associated factors. J Neurosurg. 2013;119(6)
Supplementary files
Review
For citations:
Nikitina T.V., Vorotnikova S.Yu., Dzeranova L.K., Lapshina A.M., Azizyan V.N., Kuzmin A.G. Clinical case of gonadotropinoma, which occurs for a long time under the guise of hyperprolactinemia. Bulletin of Reproductive Health. 2024;3(1):68-74. (In Russ.) https://doi.org/10.14341/brh12710
Views:
283
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
